Related Experiment Video
Updated: May 6, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Pre-hypertension: another 'pseudodisease'?
Pascal Meier1, Franz H Messerli, Andreas Baumbach
1The Heart Hospital, University College London Hospitals UCLH, 16-18 Westmoreland Street, London W1T 7HA, UK. pascalmeier74@gmail.com.
Insights
Pre-hypertension, defined as blood pressure between 120-140/80-90 mmHg, is a significant marker for increased cardiovascular risk. This finding prompts re-evaluation of hypertension thresholds and diagnostic criteria.
Area of Science:
- Cardiology
- Public Health
- Epidemiology
Background:
- Hypertension is a major cardiovascular risk factor, with diagnostic thresholds progressively lowered over time.
- Defining the precise blood pressure level causing end-organ damage remains challenging.
- Current trends label blood pressures from 120-140/80-90 mmHg as 'pre-hypertension'.
Purpose of the Study:
- To evaluate the scientific justification for lowering hypertension thresholds.
- To assess the cardiovascular risk associated with pre-hypertension.
- To discuss the implications of redefining 'pre-hypertension' as 'hypertension'.
Main Methods:
- Meta-analysis of existing studies on blood pressure and cardiovascular risk.
- Review of current expert committee guidelines and scientific literature.
- Analysis of data from Huang et al. published in BMC Medicine.
Main Results:
- A meta-analysis indicates pre-hypertension (120-140/80-90 mmHg) is a significant marker of increased cardiovascular risk.
- The study questions whether pre-hypertension is an independent risk factor or merely a marker.
- Controversy exists regarding the benefits of treating pre-hypertension to reduce cardiovascular risk.
Conclusions:
- Pre-hypertension signifies increased cardiovascular risk, necessitating careful interpretation of current hypertension guidelines.
- Lowering the hypertension threshold to 120/80 mmHg could redefine a large 'healthy' population as patients.
- Further research is needed to clarify the independent risk status of pre-hypertension and the efficacy of its treatment.
Abstract:
Hypertension is one of the most important and common cardiovascular risk factors. Defining the level at which blood pressure starts causing end-organ damage is challenging, and is not easily answered. The threshold of blood pressure defining hypertension has progressively been reduced over time, from systolic >160 mmHg to >150 mmHg, then to >140 mmHg; and now even blood pressures above 130 to 120 mmHg are labeled as 'pre-hypertension' by some expert committees. Are interest groups creating another 'pseudodisease' or is this trend scientifically justified? A recent meta-analysis published in BMC Medicine by Huang et al. clearly indicates that pre-hypertension (120 to 140/80 to 90 mmHg) is a significant marker of increased cardiovascular risk. This raises the question as to whether we now need to lower the threshold of 'hypertension' (as opposed to 'pre-hypertension') to >120/80 mmHg, redefining a significant proportion of currently healthy people as 'patients' with an established disease. These data need to be interpreted with some caution. It is controversial whether pre-hypertension is an independent risk factor or just a risk marker and even more controversial whether treatment of pre-hypertension will lower cardiovascular risk. Please see related research: http://www.biomedcentral.com/1741-7015/11/177.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension I: Introduction
Hypertension II: Pathophysiology
Alterations in Blood Pressure
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
Hypertension and Regulation of Blood Pressure
Measurement of Blood Pressure

